Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 01, 2023 08:00 ET | Source: Miromatrix Medical Inc.

Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure

Combines Miromatrix’s expertise in bioengineered organs with Baxter’s leadership in critical care delivery and organ support therapiesIncludes intended Phase I clinical trial designed to generate key...
February 01, 2023 07:59 ET | Source: Miromatrix Medical Inc.

Miromatrix Provides Update on miroliverELAP

EDEN PRAIRIE, Minn., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
December 14, 2022 17:30 ET | Source: Miromatrix Medical Inc.

Miromatrix Announces FDA Clinical Hold on IND Application for miroliverELAP

EDEN PRAIRIE, Minn., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
November 21, 2022 07:01 ET | Source: Miromatrix Medical Inc.

Miromatrix Announces Participation in the Piper Sandler 34th Annual Healthcare Conference

EDEN PRAIRIE, Minn., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
November 14, 2022 16:01 ET | Source: Miromatrix Medical Inc.

Miromatrix Reports Filing of IND, Third Quarter 2022 Results, and Provides Corporate Update

EDEN PRAIRIE, Minn., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
November 03, 2022 16:01 ET | Source: Miromatrix Medical Inc.

Miromatrix to Report Third Quarter 2022 Financial Results

EDEN PRAIRIE, Minn., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
October 19, 2022 07:00 ET | Source: Miromatrix Medical Inc.

Miromatrix CEO Jeff Ross Delivering Keynote Address at ARMI | BioFabUSA 2022 Fall Summit: Meeting in the Millyard

EDEN PRAIRIE, Minn., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
October 05, 2022 16:01 ET | Source: Miromatrix Medical Inc.

Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa

EDEN PRAIRIE, Minn., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
September 26, 2022 16:01 ET | Source: Miromatrix Medical Inc.

Miromatrix CEO Jeff Ross to Present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event

EDEN PRAIRIE, Minn., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
September 20, 2022 16:01 ET | Source: Miromatrix Medical Inc.

Miromatrix CEO Jeff Ross to Present at the Bioregate European Regenerative Medicine Forum

EDEN PRAIRIE, Minn., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...